Economic guidance for policymakers battling an unprecedented set of circumstances.
Modern cancer treatments are growing increasingly successful but unaffordable. Life-insurance policies could be the answer.
Research identifies a little-noticed winner from recent revolutionary advances in cancer treatments: the life-insurance industry.
What if there were a simple, straightforward methodology to measure an investment’s expected return—in multiple types of investments?